|Dr. Deepak Hegde is an alumnus of IT-BHU. He completed M. Pharm in 1993 from IT-BHU in Pharmacognosy and Phytochemistry under the guidance of Dr. Ratan Lal Khosa. He was at IT-BHU from Aug 1991 to Feb 1993 for his M. Pharm study.
WuXi PharmaTech Co., Ltd. Appoints Deepak Hegde as VP of Formulation Development Services
SHANGHAI, China, July 24 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China's leading supplier of pharmaceutical R&D outsourcing services announced today the appointment of Dr. Deepak Hegde as Vice President of Formulation Development Services.
Before joining WuXi PharmaTech, Dr. Hegde served as General Manager of Drug Delivery Research Lab at USV Ltd., one of the largest Indian generic pharmaceutical companies. In this position, Dr. Hedge oversaw the development and registration of formulations to be exported to the American and European markets. His undertakings at USV Ltd. involved closely collaborating with the US-FDA on Abbreviated New Drug Applicant (ANDA) products and EMEA for the Product Dossiers for the European markets.
Prior to joining USV Ltd., Dr. Hegde worked in Sandoz (the generic arm of Novartis). At Sandoz, he implemented cutting-edge drug development technology transfers from Novartis development sites in India to Novartis commercial launch sites in Austria, Bangladesh, and South Africa.
Dr. Hegde received his Bachelor of Pharmacy degree from the University of Mumbai (formerly the University of Bombay) before going on to receive a Master of Pharmacy in Pharmacognosy and Phytochemistry from Banaras Hindu University. He returned to University of Mumbai to earn a Ph.D. in Biopharmaceutics and Pharmacokinetics in 1996, and has most recently received a Master of Financial Management from Somaiya Institute of Management Studies and Research. Dr. Hegde is a lifetime member of the Indian Pharmaceutical Association.